Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.84 | -$0.84 | -$0.84 |
Q2 2024 | 1 | -$0.75 | -$0.75 | -$0.75 |
Q3 2024 | 1 | -$0.63 | -$0.63 | -$0.63 |
Q1 2025 | 1 | -$0.64 | -$0.64 | -$0.64 |
Q2 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
Q3 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
Q4 2025 | 1 | -$0.54 | -$0.54 | -$0.54 |
Creative Medical Technology Holdings, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.75 earnings per share for the quarter, topping analysts' consensus estimates of $-0.85 by $0.1. The company had revenue of 0 for the quarter and had revenue of 9,000 for the year. Creative Medical Technology Holdings, Inc. has generated $-4 earnings per share over the last year ($-3.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.54. Creative Medical Technology Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/08/2024 | Q3 2024 | -$0.85 | -$0.75 | 0.1 | $0 | $0 |
08/09/2024 | Q2 2024 | -$0.84 | -$1.11 | -0.27 | $8,000 | $8,000 |
05/10/2024 | Q1 2024 | -$1.15 | -$0.73 | 0.42 | $0 | |
04/29/2024 | Q4 2023 | -$1.21 | $3,000 | |||
11/14/2023 | Q3 2023 | -$0.86 | -$1.02 | -0.16 | $6,000 | |
08/11/2023 | Q2 2023 | -$0.83 | -$0.78 | 0.05 | $15,000 | $0 |
05/12/2023 | Q1 2023 | -$1.00 | -$0.70 | 0.3 | $0 | |
05/01/2023 | Q4 2022 | -$4.37 | $18,600 | |||
11/10/2022 | Q3 2022 | -$0.13 | -$0.70 | -0.57 | $110,000 | $55,000 |
08/12/2022 | Q2 2022 | -$0.15 | -$2.25 | -2.1 | $100,000 | $10,000 |
05/13/2022 | Q1 2022 | -$0.14 | -$1.79 | -1.65 | $15,000 | |
03/30/2022 | Q4 2021 | -$0.23 | -$11.13 | -10.9 | $67,754 | |
11/15/2021 | Q3 2021 | -$7.52 | $10,000 | |||
08/16/2021 | Q2 2021 | -$12.52 | $10,000 | |||
05/17/2021 | Q1 2021 | $122.20 | $0 | |||
03/17/2021 | Q4 2020 | -$251.26 | $17,500 | |||
11/13/2020 | Q3 2020 | $5.80 | $77,000 | |||
08/14/2020 | Q2 2020 | -$54.46 | $27,900 | |||
05/15/2020 | Q1 2020 | $450.00 | $42,100 | |||
04/06/2020 | Q4 2019 | -$1,154.54 | $-4,400 |
Creative Medical Technology Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
In the previous quarter, Creative Medical Technology Holdings, Inc. (:CELZ) reported $-0.75 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.85 by $0.1.
The conference call for Creative Medical Technology Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Creative Medical Technology Holdings, Inc.'s latest earnings report can be read online.
Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded annual revenue of $9,000.
Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded net income of $9,000. Creative Medical Technology Holdings, Inc. has generated $-3.76 earnings per share over the last four quarters.
Creative Medical Technology Holdings, Inc. (:CELZ) has a price-to-earnings ratio of -0.54 and price/earnings-to-growth ratio is -0.08.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED